Although there are no significant differences in the proportions of CD3+ T cells and CD8+ T cells among the groups, the proportion of CD8+CD69+ T cells significantly increase in tumor tissues treated with RT+MnBTC-Ru. The gene discussed is CD8A; the disease is neoplasm.